Previous 10 | Next 10 |
Alnylam Pharmaceuticals ' (NASDAQ: ALNY) stock went vertical in the past month -- up over 50% -- and there might be even more growth on the way. Sales of its top-earning medicines are booming, and breakthroughs in clinical trials have added to the enthusiasm. But now could also ...
Maraganore brings more than 35 years of scientific, research and development, capital markets and managerial leadership expertise to ProKidney Fox joins Board with more than 25 years of healthcare investment banking, finance and capital markets experience WINSTON-SALEM, N....
Baillie Gifford’s 13F portfolio value decreased from ~$143B to ~$97.51B this quarter. They increased Spotify and Royalty Pharma while decreasing Cloudflare, Petrobras, BeiGene, CBRE Group, Teladoc, and Peloton Interactive. The top three positions are Moderna, Tesla Motors, ...
Alnylam's APOLLO-B study was a success, with the drug patisiran hitting the trial's primary endpoint and some secondary endpoints in the treatment of hATTR-CM. The APOLLO-B results should drive an FDA approval in 2023, expanding the drug's addressable market by 2x-3x-plus while also d...
InvestorPlace - Stock Market News, Stock Advice & Trading Tips Gene editing stocks are the talk of Wall Street today as a number of biotech titans enjoy strong gains. It seems a breakthrough clinical trial from Alnylam Pharmaceuticals (NASDAQ: ALNY ) has lifted the entire industry. ...
Moderna ( MRNA ), CVS Health ( CVS ), and Regeneron ( REGN ) dominated the top five intraday gainers in the S&P 500 on Wednesday after all three companies reported better than expected financials for 2Q 2022 before the market opened. Recording the sharpest intraday g...
Gainers: Kaspien Holdings ( KSPN ) +136% . Heart Test Laboratories ( HSCS ) +92% . Poseida Therapeutics ( PSTX ) +74% . Eargo ( EAR ) +73% . Ping Identity ( PING ) +60% . Applied DNA ( APDN ) +53% . Golden Sun ( ...
InvestorPlace - Stock Market News, Stock Advice & Trading Tips Source: Bukhta Yurii / Shutterstock.com Helius Medical (NASDAQ: HSDT ) stock is rocketing higher on Wednesday despite a lack of news from the medical device holding company. Instead, the price of HSDT stock is...
InvestorPlace - Stock Market News, Stock Advice & Trading Tips Today, Alnylam Pharmaceuticals (NASDAQ: ALNY ) revealed positive top-line results for the company’s transthyretin-mediated amyloidosis treatment, patisiran. Alnylam’s drug reportedly met its prima...
Shares of Alnylam Pharmaceuticals (NASDAQ: ALNY) are poised to post a new all-time high upon market open Wednesday. The RNA interference (RNAi) drug specialist's stock price rose by as much as 53% in premarket action this morning. What's fueling this supercharged move higher tod...
News, Short Squeeze, Breakout and More Instantly...
Alnylam Pharmaceuticals Inc. Company Name:
ALNY Stock Symbol:
NASDAQ Market:
Alnylam Pharmaceuticals Inc. Website:
Alnylam Pharmaceuticals, Inc. (Nasdaq: ALNY), the leading RNAi therapeutics company, announced today that it will report financial results for the second quarter ending June 30, 2024 on Thursday, August 1, 2024, before the U.S. financial markets open. Management will provide an update on th...
2024-06-29 16:24:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...